skip to Main Content

Precision Medicine Enablement via Advanced Diagnostics Workgroup

Did you miss the November Call for Member Feedback? Watch the recordings here.

Workgroup Co-Leads

Brian Caveney pic

Co-Lead: Brian Caveney, MD, JD, MPH, President, Enterprise-Wide Chief Medical Officer, Labcorp

Jill Bates headshot

Co-Lead: Jill Bates, PharmD, MS, BCOP, FASHP, PHASER Pharmacy Program Manager, Durham VA Health Care System; Associate Professor of Clinical Education, UNC Eshelman School of Pharmacy

  • Areas of Further Work
  • Workgroup Participants

Areas of Further Work

  1. Regulation: Strengthen the relationship of the FDA with laboratories that provide pharmacogenomic testing to optimize its usefulness to patients and providers
  2. HIT and AI: Develop tools that enable the practice of precision medicine and advanced diagnostics?
  3. Marketplace Strategy: Create and implement a plan that promotes precision medicine literacy and application to clinical care
  4. Education and Public Awareness: Standardize a process for precision medicine care and support providers in its delivery and adoption
  5. Evidence-Based Process: Create an evidence-based process that supports precision medicine data and enables effective understanding, awareness and interpretation

Workgroup Participants

  • Philip Empey, Pharm.D., Ph.D., Director, PGx Center of Excellence; Associate Director, Institute for Precision Medicine; Associate Professor, Dept. of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy
  • Cyrine Eliana-Haidar, Pharm.D., BCPS, BCOP, Clinical Pharmacogenetics Coordinator, St. Jude Children’s Research Hospital
  • Ghada Elnashar, Pharm.D., MS, Associate Director, Medical Affairs, OneOme
  • Brian Erpenbeck, National Accounts & Strategic Partnerships, Biotheranostics
  • Jane Gilbert, CPA, Director, Retiree Health Care, Kentucky Teachers’ Retirement System
  • Jacques Turgeon, BPharm, Ph.D., Chief Scientific Officer, Tabula Rasa; CEO, Precision Pharmacotherapy Research and Development Institute
  • Sarah Mallak, Pharm.D., Director, Clinical Product Design and Strategy, Genoa Healthcare
  • Anthony Morreale, Pharm.D., MBA, BCPS, FASHP, Associate Chief Consultant for Clinical Pharmacy Services & Policy, Pharmacy Benefits Management, Veterans Affairs Central Office
  • Chet Robson, DO, MHCDS, FAAFP, Medical Director, Walgreens Co.
  • Annette K Taylor, MS, PhD, FACMG, Associate Vice President, LabCorp; Scientific Director, Molecular Genetics
  • Jamie Wilkey, Pharm.D., RPh, Certified Pharmacogenomics Pharmacist, Functional Wellness Consultant; Founder & CEO, Arches Health
  • Cari Lalande, Pharm.D., Director, Clinical Pharmacogenomics, RxGenomix
  • Rustin Crutchley, Pharm.D., AAHIVP, Associate Professor, Washington State University, College of Pharmacy and Pharmaceutical Sciences, Department of Pharmacotherapy
  • Kristin Wiisanen, Pharm.D., FAPhA, FCCP, Clinical Professor, Department of Pharmacotherapy and Translational Research; Director, Graduate Program in Precision Medicine; Associate Director, UF Health Precision Medicine Program; Director, Continuing Professional Education, University of Florida College of Pharmacy
  • Jennifer Hockings, Pharm.D., Ph.D., BCPS, Pharmacogenomics Clinical Specialist, Cleveland Clinic
  • Gabriela Williams, Pharm.D., BCPS, BCPP, Medical Science Liaison, Genomind
  • Betsy Bove, Ph.D., Laboratory Director, Veritas/LetsGetChecked
  • Mindy Smith, BSPharm, RPh, MHA, CMWA, Senior Vice President, Professional Affairs, Tabula Rasa HealthCare
  • Ellie Jhun, Pharm.D., Ph.D., Principle Scientist, Clinical Development Team, OneOme, LLC
Back To Top
×Close search

We need your help now more than ever!